Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × Vincristine × 30 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, Follicular 8 Lymphoma, Large B-Cell, Diffuse 7 Sarcoma, Ewing 5 Rhabdomyosarcoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 4 Lymphoma 4 Leukemia, Biphenotypic, Acute 4 Sarcoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Wilms Tumor 2 Rhabdomyosarcoma, Embryonal 2 Recurrence 2 Osteosarcoma 2 Neuroblastoma 2 Desmoplastic Small Round Cell Tumor 2 Waldenstrom Macroglobulinemia 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Rhabdomyosarcoma, Alveolar 1 Rhabdoid Tumor 1 Pleuropulmonary blastoma 1 Plasmablastic Lymphoma 1 PRETEXT I Hepatoblastoma 1 Neurofibromatosis 1 1

Interventions

Specimen Handling 8 Biopsy 8 fludarabine 6 Azacitidine 6 venetoclax 5 Whole-Body Irradiation 4 Busulfan 4 ruxolitinib 3 decitabine and cedazuridine drug combination 3 Injections 3 Cytarabine 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 fludarabine phosphate 2 Tacrolimus 2 Stem Cell Transplantation 2 Mycophenolic Acid 2 Liposomes 2 Granulocyte Colony-Stimulating Factor 2 Daunorubicin 2 Cyclosporins 2 Cyclophosphamide 2 CPX-351 2 ponatinib 1 pevonedistat 1 peginterferon alfa-2b 1 onvansertib 1 olutasidenib 1 nilotinib 1 luspatercept 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡